Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines-Reference-Cited by-同舟云学术

Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines

Published:2008-08-15 Issue:4 Volume:113 Page:690-700
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kidd Mark,Drozdov Ignat,Joseph Richard,Pfragner Roswitha,Culler Michael,Modlin Irv

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference39 articles.

1. A 5-decade analysis of 13,715 carcinoid tumors;Modlin;Cancer.,2003

2. Neuroendocrine tumors of the diffuse neuroendocrine system;Gustafsson;Curr Opin Oncol.,2008

3. Bronchopulmonary neuroendocrine tumors;Gustafsson;Cancer.,2008

4. Metastatic carcinoid tumors: a clinical review;Zuetenhorst;Oncologist.,2005

5. The current status of gastroenteropancreatic neuroendocrine tumors;Modlin;Lancet Oncol.,2008

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatostatin and Somatostatin Receptors in Tumour Biology;International Journal of Molecular Sciences;2023-12-28

2. Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies;International Journal of Molecular Sciences;2023-02-10

3. Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms;Journal of Clinical Medicine;2021-02-01

4. Efficacy of a Novel Second-Generation Somatostatin-Dopamine Chimera (TBR-065) in Human Medullary Thyroid Cancer: A Preclinical Study;Neuroendocrinology;2020-10-19

5. Oncological management of advanced neuroendocrine tumours (Review);Molecular and Clinical Oncology;2020-06-25